Ferenc Jakab - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ferenc Jakab

Showing results (141-150 of 143) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 143 results.

Plos Pathogens|June 24, 2022

Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.

Plos Pathogens|February 4, 2022

Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.

British Journal of Pharmacology|August 27, 2024

The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19Henrietta Papp, Emese Tóth, Judit Bóvári-Biri, et al.

Pageof 15

Search research articles

Showing results (141-150 of 143) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 143 results.

Plos Pathogens|June 24, 2022

Correction: Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.

Plos Pathogens|February 4, 2022

Recombinant Lloviu virus as a tool to study viral replication and host responsesAdam J Hume, Baylee Heiden, Judith Olejnik, et al.

British Journal of Pharmacology|August 27, 2024

The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19Henrietta Papp, Emese Tóth, Judit Bóvári-Biri, et al.

Pageof 15